Refine by
Molecular Imaging Articles & Analysis: Older
27 news found
As part of a larger, strategic collaboration, the two companies are now expanding upon a pilot program that utilizes Next, Tempus’ care pathway intelligence platform, to help physicians determine if their patients with NSCLC may benefit from guideline-directed molecular testing, including testing for epidermal growth factor receptor (EGFR) mutations. ...
ByTempus
His main areas of research are imaging of abdominal organs and cardio-vascular diseases, molecular imaging and population imaging. ...
ByFluidda
Check out the advantages that our specialized imaging agents can provide to your research! Come and visit at the World Molecular Imaging Congress (WMIC) 2022 in Miami to discover our innovative range of Viscover products and their exciting application possibilities. We look forward to seeing you to discuss your diagnostic imaging ...
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the 2022 SNMMI Image of the Year Award and JNM Editors’ Choice Award for Overall Best Article in 2021, respectively. Both use FAPI as the primary indicator and further underscore its potential impact as a novel radiopharmaceutical. Each year, SNMMI chooses an ...
BySOFIE
Basilion delivered papers focused on the use of molecular probes for guided, precision surgery to the European Society of Molecular Imaging, the World Society of Molecular Imaging, and the Netherlands Science ...
Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea’s confocal laser endomicroscopy platform to diagnose ...
Gauden will retain his current responsibilities as President, Research and Development and Chief Scientific Officer and report to Bracco Imaging CEO Fulvio Renoldi Bracco. Terri Wilson, President of BED Inc. ...
Ron Heeren from the Maastricht Multi Modal Molecular Imaging Institute (M4I), a world-leading institute in lipid Mass Spectrometry Imaging; Dr. ...
The applications of the tailor-made software tools include: DNA sequence editing and primer design, NGS and metagenomics analysis and statistics, Sequence alignment and phylogenetics, Microarray analysis, Metabolomic and proteomic data analysis, Molecular graphics systems, Microscope image processing and gel analysis, 2D and 3D molecular ...
The lipid composition varies from tissue to tissue, even within different cells of the tissue. “MALDI-Imaging is a well-known solution provided by Creative Proteomics. The result gives both molecular–histological maps from the localization and identification of lipid biomolecules based on the mass-to-charge ratio (m/z) and can detect up to a ...
Of 60 patients originally planned for ADT monotherapy, only 25% (15) were still due to receive ADT monotherapy after Axumin PET/CT imaging. Axumin, a novel amino acid-based radiopharmaceutical, is FDA-approved for PET imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment. ...
ODS Medical is bringing together the power of machine learning and molecular imaging to develop optical biopsy tools based on Raman spectroscopy. ...
These potential responders are qualified for their personalized therapy via diagnostic molecular imaging of target expression in their tumor lesions. This emerging field of medicine implies that only those patients who have the capacity to benefit from the treatment will actually receive the therapy, potentially minimizing the time and cost of clinical trials ...
This novel platform is also capable of hosting other proprietary endomicroscopic architectures with imaging capabilities at other wavelengths supporting fluorescence-guided surgery and molecular imaging. ...
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. ...
Edinburgh Molecular Imaging Ltd, a company developing theragnostic agents targeting cancer, today announces the closing of a £3.1 million financing, which will be used to advance new molecular targeted systemic radiotherapy agents, EMT-100 and EMT-101 to be ready for clinic development. ...
MEDPHOT consortium aims to develop light-based molecular imaging solution for pulmonary diseases Mauna Kea Technologies today announced it is part of a molecular imaging consortium that was awarded €5.4 million by the Perspective Program of the Netherlands Organization for Scientific Research (NWO). ...
” Seno Medical Instruments™, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging a molecular partner to ultrasound. Seno Medical’s Imagio® Breast Imaging System fuses opto-acoustic ...
Edinburgh Molecular Imaging (EM Imaging), the optical molecular imaging company, today announces the appointment of Dr Bernhard Sixt as Chief Executive Officer, effective immediately. ...
Under the terms of the agreement, Quest Medical Imaging has received an undisclosed lump sum payment to provide 12 Spectrum™ platforms to the centers that will participate in the Phase III pivotal trial sponsored by SurgiMab. The Quest Spectrum™ Fluorescence Imaging Platform is designed and developed for open and ...
BySurgiMab